RU94045856A - Трансдермальный препарат продленного действия с антиостеопоротической активностью - Google Patents

Трансдермальный препарат продленного действия с антиостеопоротической активностью

Info

Publication number
RU94045856A
RU94045856A RU94045856/14A RU94045856A RU94045856A RU 94045856 A RU94045856 A RU 94045856A RU 94045856/14 A RU94045856/14 A RU 94045856/14A RU 94045856 A RU94045856 A RU 94045856A RU 94045856 A RU94045856 A RU 94045856A
Authority
RU
Russia
Prior art keywords
prolonged action
transdermal preparation
estrogen
activity
antiosteoporosis
Prior art date
Application number
RU94045856/14A
Other languages
English (en)
Other versions
RU2119337C1 (ru
Inventor
Эльгер Вальтер
De]
Шнейдер Биргитт
Еттель Михаель
Эрнст Михаель
Хюблер Дорис
Диттген Михаель
Original Assignee
Энтек Гезельшафт фюр Эндокринологише Технологи мбХ (DE)
Энтек Гезельшафт фюр Эндокринологише Технологи мбХ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Энтек Гезельшафт фюр Эндокринологише Технологи мбХ (DE), Энтек Гезельшафт фюр Эндокринологише Технологи мбХ filed Critical Энтек Гезельшафт фюр Эндокринологише Технологи мбХ (DE)
Publication of RU94045856A publication Critical patent/RU94045856A/ru
Application granted granted Critical
Publication of RU2119337C1 publication Critical patent/RU2119337C1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Объектом изобретения является трансдермальный препарат продленного действия с антиостеопоротической активностью, содержащий эстроген в качестве активного вещества и по меньшей мере один носитель или вспомогательное вещество, прич м указанные компоненты и их количество выбрано с обеспечением непрерывного выделения эстрогена в течение по меньшей мере 24 ч, при этом в качестве эстрогена препарат содержит эстриол в эффективном количестве.

Claims (1)

  1. Объектом изобретения является трансдермальный препарат продленного действия с антиостеопоротической активностью, содержащий эстроген в качестве активного вещества и по меньшей мере один носитель или вспомогательное вещество, прич м указанные компоненты и их количество выбрано с обеспечением непрерывного выделения эстрогена в течение по меньшей мере 24 ч, при этом в качестве эстрогена препарат содержит эстриол в эффективном количестве.
RU94045856A 1992-03-21 1993-03-18 Трансдермальный препарат продленного действия с антиостеопоротической активностью RU2119337C1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4209295 1992-03-21
DEP4209295.7 1992-03-21

Publications (2)

Publication Number Publication Date
RU94045856A true RU94045856A (ru) 1996-08-20
RU2119337C1 RU2119337C1 (ru) 1998-09-27

Family

ID=6454737

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94045856A RU2119337C1 (ru) 1992-03-21 1993-03-18 Трансдермальный препарат продленного действия с антиостеопоротической активностью

Country Status (12)

Country Link
US (1) US5614213A (ru)
EP (1) EP0630248B1 (ru)
JP (1) JPH07504672A (ru)
AT (1) ATE172118T1 (ru)
AU (1) AU665997B2 (ru)
CA (1) CA2131822C (ru)
DE (1) DE59309063D1 (ru)
DK (1) DK0630248T3 (ru)
ES (1) ES2123666T3 (ru)
HU (1) HU218290B (ru)
RU (1) RU2119337C1 (ru)
WO (1) WO1993018774A1 (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19635883A1 (de) * 1996-09-04 1998-03-05 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit einer Östriol enthaltenden Wirkstoffkombination
DE19918644A1 (de) * 1999-04-16 2000-10-26 Jenapharm Gmbh Pharmazeutische Zusammensetzungen zur lokalen, intradermalen Applikation von Estrogenen
DE102004023984A1 (de) * 2004-05-14 2005-12-08 Hf Arzneimittelforschung Gmbh Filmförmiges, oral zu verabreichendes Arzneimittel, enthaltend Estriol
TW201946617A (zh) 2017-04-28 2019-12-16 日商日東電工股份有限公司 經皮吸收製劑

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3510555A1 (de) * 1985-03-21 1986-09-25 Schering AG, 1000 Berlin und 4709 Bergkamen Estriolester
US5108995A (en) * 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
EP0573133A1 (de) * 1988-10-27 1993-12-08 Schering Aktiengesellschaft Mittel zur transdermalen Applikation das Gestoden enthält
DE3910578A1 (de) * 1989-03-29 1990-10-04 Schering Ag Mittel zur transdermalen applikation enthaltend gestoden
US5116828A (en) * 1989-10-26 1992-05-26 Nippon Zoki Pharmaceutical Co., Ltd. Pharmaceutical composition for treatment of osteoporosis
DE69201725T2 (de) * 1991-02-26 1996-04-18 Procter & Gamble Pharmaceuticals, Inc. (An Ohio Corp.), Norwich, N.Y. Behandlungsmethoden für osteoporose.

Also Published As

Publication number Publication date
ES2123666T3 (es) 1999-01-16
CA2131822C (en) 2002-12-17
EP0630248A1 (de) 1994-12-28
WO1993018774A1 (de) 1993-09-30
US5614213A (en) 1997-03-25
DK0630248T3 (da) 1999-06-23
AU665997B2 (en) 1996-01-25
HUT68213A (en) 1995-06-28
EP0630248B1 (de) 1998-10-14
AU3750093A (en) 1993-10-21
JPH07504672A (ja) 1995-05-25
DE59309063D1 (de) 1998-11-19
HU218290B (en) 2000-07-28
CA2131822A1 (en) 1993-09-22
HU9402698D0 (en) 1994-11-28
ATE172118T1 (de) 1998-10-15
RU2119337C1 (ru) 1998-09-27

Similar Documents

Publication Publication Date Title
CA2006028A1 (fr) Composition cosmetique ou pharmaceutique contenant des microspheres de polymeres ou de corps gras chargees d'au moins un produit actif
HU892559D0 (en) Process for the preparation of transdermal pharmaceutical composition suitable for systemic administration, containing deprenyl as active ingredient
GEP20002211B (en) Taxoids, Preparation Thereof, Pharmaceutical Compositions Containing Same
CA2068324A1 (en) Metal-peptide compositions and methods for stimulating hair growth
MX9500159A (es) Preparacion farmaceutica percutanea.
HU900221D0 (en) Fungicid composition comprising acyl-amino-benzamides as active ingredient and process for preparation thereof
RU94046044A (ru) Новые 7 бета -замещенные 4-аза- 5 альфа -холестан-оны в качестве ингибиторов 5 альфа -редуктазы, фармацевтическая композиция на их основе, способ ее получения
PT86186A (en) Process for the preparation of benzimidazol derivatives and of pharmaceutical compositions containing the same
HUT64013A (en) Process for producing hiv-inhibiting phenylacetamide derivatives and pharmaceutical compositions comprising such compounds as active ingredient
ATE55695T1 (de) Verwendung von defibrotid zur herstellung pharmazeutischer zusammensetzungen zur behandlung peripherer arteriopathien.
HUP9900365A3 (en) N-aryl-1,2,4-triazolin-5-on derivatives, preparation and use thereof, insecticide, arachnicide and nematocide compositions containing these compounds as active ingredients
ATE221391T1 (de) Konjugat enthaltend dtpa und albumin zur individuellen dosierung von arzneimitteln
AU583255B2 (en) New benzenesulfonyl-lactams, process for their preparation and their use as active substances of pharmaceutical compositions
GEP19991872B (en) Novel Taxoids, Preparations Thereof, and Pharmaceutical Compositions Containing Same
JPS55111494A (en) Monophosphonate compound* its manufacture and therapeutic composition containing same as active ingredient
HUT59116A (en) Process for producing oxazole derivatives and pharmaceutical compositions comprising oxazole derivatives as active ingredient
RU94045856A (ru) Трансдермальный препарат продленного действия с антиостеопоротической активностью
ATE158947T1 (de) Hautregenerierende kosmetische zusammensetzung
HUT49320A (en) Process for producing ornithine derivatives and pharmaceutical compositions containing them as active components
AU4482489A (en) Novel tetrahydropyrimidine derivatives, process for their preparation and insecticides containing same as active ingredients
AU3499389A (en) Compounds with central analgesic activity, process for their preparation and pharmaceutical compositions containing them
CA2259584A1 (en) Plasters containing isosorbide dinitrate
HU900209D0 (en) Herbicid composition comprising n-phenyl-tetrahidroindazol-derivatives as active ingredient and process for preparation thereof
HU900075D0 (en) Herbicid composition comprising sulfonyl-urea as active ingredient and process for preparation thereof
HUT46323A (en) Compositions against pestiferous insects and process for producing compositions against zooparasites and comprising milbemycin derivatives as active ingredient and for producing the active ingredients